John Bohnsack
Pediatric Rheumatology · Salt Lake City, UTNPI 1609955277
Payments from drug & device makers
Across 76 payments — averaging $7087.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Research & Development, LLC$364K
- Pfizer$75K
- E.r. Squibb & Sons, L.L.C.$72K
- Takeda Pharmaceuticals U.S.A., Inc.$16K
- AbbVie$13K
Across 3 payments — averaging $1490.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$4K
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Research & Development, LLC | 23 | $363,717 |
| Pfizer | 30 | $75,050 |
| E.r. Squibb & Sons, L.L.C. | 7 | $71,624 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $15,644 |
| AbbVie | 9 | $12,625 |
How this compares
Too few pediatric rheumatology providers in Utahto place this figure against a meaningful peer group, so we don't.
Other pediatric rheumatology in Salt Lake City
- Aimee HershSalt Lake City$178K
- Sara SternSalt Lake City$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.